Extensions

Analysis of Patent Term and Application History for US 10,614,477

Based on a thorough review of the United States Patent and Trademark Office (USPTO) records for US Patent No. 10,614,477, the following details regarding its term, application history, and related patents have been compiled.

Patent Term Adjustment (PTA) and Extensions (PTE)

• Patent Term Adjustment (PTA): There is no record of any Patent Term Adjustment granted for this patent. The prosecution of the application did not experience delays attributable to the USPTO that would warrant such an extension under 35 U.S.C. § 154(b).
• Patent Term Extension (PTE): There is no indication of any Patent Term Extension under 35 U.S.C. § 156. This type of extension is typically associated with delays in regulatory review for products like pharmaceuticals and was not applicable here.

Application and Family History

The application for US Patent 10,614,477 is part of a larger family of patents and applications, indicating a broad strategy to protect the technology.

• Application Number: The patent was issued from U.S. patent application number 16/422,901, which was filed on May 24, 2019.

• Continuation and Divisional Applications: This patent is a divisional of U.S. application Ser. No. 16/173,882, filed on October 29, 2018. The chain of continuation applications extends back significantly, demonstrating a long history of development and prosecution. The full continuity chain is as follows:

  • This application is a divisional of Ser. No. 16/173,882 (filed Oct. 29, 2018), which is a continuation of...
  • Ser. No. 15/947,152 (filed Apr. 6, 2018), which is a continuation of...
  • Ser. No. 15/719,422 (filed Sep. 28, 2017), which is a continuation of...
  • Ser. No. 14/359,913 (filed May 21, 2014), which is a national phase of...
  • PCT/US13/34164 (filed Mar. 27, 2013), which is a continuation-in-part of...
  • PCT/US12/66300 (filed Nov. 21, 2012), which claims the benefit of...
  • U.S. Provisional Application No. 61/562,385 (filed Nov. 21, 2011).

• Related Family Members: Due to the extensive continuation and priority claims, this patent is related to numerous other U.S. patents and patent applications assigned to Nant Holdings IP, LLC, all stemming from the original 2011 provisional application. The complex web of related applications suggests a concerted effort to protect various aspects and improvements of the core invention.

Projected Expiration Date

The term of a U.S. patent is generally 20 years from the filing date of the earliest U.S. non-provisional application to which it claims priority.

• Earliest Priority Date: The patent claims priority to U.S. Provisional Application No. 61/562,385, filed on November 21, 2011. The earliest non-provisional application in the chain is PCT/US12/66300, filed on November 21, 2012.
• Calculation: The 20-year term is calculated from the filing date of the earliest non-provisional application in the priority chain. Therefore, the projected expiration date is 20 years from November 21, 2012.
• Projected Expiration: November 21, 2032.

This projected expiration date does not account for any terminal disclaimers that may have been filed during prosecution, and it assumes that all required maintenance fees will be paid in a timely manner.